No Prescription |
 |
 | ||
|
Flucan Vaginal Diflucan |
|
| ||
No Prescription » Prescription Drugs 8 » Flucan Vaginal Diflucan Product Origin: EU (Turkey) This product is able to be sourced and supplied at excellent prices because of favourable cross border currency conversions. All products are authentic brand names and will include a product information insert in English. Medical Information: Fluconazole capsules suspension and infusion all contain the active ingredient fluconazole which is a type of medicine called a triazole antifungal. (NB. Fluconazole is also available without a brand name ie as the generic medicine.) Fluconazole is used to treat infections with fungi and yeasts. Fluconazole kills the fungi that are causing an infection by interfering with their cell membranes. It works by stopping the fungi from producing a substance called ergosterol which is an essential component of fungal cell membranes. The disruption in production of ergosterol causes holes to appear in the fungal cell membrane. The cell membranes of fungi are vital for their survival. They keep unwanted substances from entering the cells and stop the contents of the cells from leaking out. As fluconazole causes holes to appear in the cell membranes essential constituents of the fungal cells can leak out. This kills the fungi and treats the infection. Fluconazole is used to treat a number of different types of fungal and yeast infections particularly those caused by Candida or Cryptococcus species of fungi. It can be taken by mouth or may be administered via a drip into a vein (intravenous infusion) depending on the type and severity of the infection. The length of treatment will also depend on the type and severity of the infection for example vaginal thrush can normally treated with a single dose by mouth while some other infections may require six to eight weeks of treatment. What is it used for? Fungal skin infections such as athlete's foot (tinea pedis) ringworm (tinea corporis) jock itch (tinea cruris) pityriasis versicolor or Candida skin infections. Candida infections of the linings (mucosa) of the mouth (oral thrush) throat lungs or urinary tract. Internal fungal infections caused by Candida eg infections of the bloodstream urinary tract heart lungs abdomen or other widespread internal infections (systemic candidiasis). Inflammation of the vagina (vaginitis) caused by infection with Candida albicans (also known as vaginal thrush). Inflammation of the penis and/or foreskin (candidal balanitis) caused by infection with Candida albicans (also known as thrush). Fungal infections caused by Cryptococcus fungi (cryptococcosis) including cryptococcal meningitis and infections affecting the lungs or skin. Preventing relapse of disease caused by Cryptococcus fungi eg cryptococcal meningitis in people with AIDS. Preventing fungal infections in people with a weakened immune system and low white blood cell counts for example due to chemotherapy radiotherapy or bone marrow transplants. Buy Flucan Vaginal Diflucan and other Prescription Drugs 8 products online at Medstore. 4965
About Flucan Vaginal Diflucan: Product Type: Prescription Drugs 8 Flucan Vaginal ( Diflucan Generic Fluconazole ) Flucan Vaginal (Diflucan Generic Fluconazole) Diflucan Generic Fluconazole 150 mg 5 ( 5 x 1 capsule ) Diflucan Generic Fluconazole Flucan Vaginal
View more Prescription Drugs 8 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
